JP6890353B2 - 分子状水素を含む腎臓疾患の腎機能改善のための組成物 - Google Patents

分子状水素を含む腎臓疾患の腎機能改善のための組成物 Download PDF

Info

Publication number
JP6890353B2
JP6890353B2 JP2020035995A JP2020035995A JP6890353B2 JP 6890353 B2 JP6890353 B2 JP 6890353B2 JP 2020035995 A JP2020035995 A JP 2020035995A JP 2020035995 A JP2020035995 A JP 2020035995A JP 6890353 B2 JP6890353 B2 JP 6890353B2
Authority
JP
Japan
Prior art keywords
hydrogen
urinary
renal
composition
glomerulonephritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020035995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020164507A (ja
Inventor
文武 佐藤
文武 佐藤
亮介 黒川
亮介 黒川
秀介 佐々木
秀介 佐々木
佐々木　義明
義明 佐々木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miz Co Ltd
Original Assignee
Miz Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=72716937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6890353(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miz Co Ltd filed Critical Miz Co Ltd
Publication of JP2020164507A publication Critical patent/JP2020164507A/ja
Priority to US17/188,617 priority Critical patent/US20210275575A1/en
Application granted granted Critical
Publication of JP6890353B2 publication Critical patent/JP6890353B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020035995A 2019-03-26 2020-03-03 分子状水素を含む腎臓疾患の腎機能改善のための組成物 Active JP6890353B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/188,617 US20210275575A1 (en) 2019-03-26 2021-03-01 Composition for improving renal function in renal diseases containing molecular hydrogen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019057964 2019-03-26
JP2019057964 2019-03-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020203080A Division JP2021050222A (ja) 2019-03-26 2020-12-08 分子状水素を含む腎臓疾患の腎機能改善のための組成物

Publications (2)

Publication Number Publication Date
JP2020164507A JP2020164507A (ja) 2020-10-08
JP6890353B2 true JP6890353B2 (ja) 2021-06-18

Family

ID=72716937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020035995A Active JP6890353B2 (ja) 2019-03-26 2020-03-03 分子状水素を含む腎臓疾患の腎機能改善のための組成物
JP2020203080A Pending JP2021050222A (ja) 2019-03-26 2020-12-08 分子状水素を含む腎臓疾患の腎機能改善のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020203080A Pending JP2021050222A (ja) 2019-03-26 2020-12-08 分子状水素を含む腎臓疾患の腎機能改善のための組成物

Country Status (2)

Country Link
US (1) US20210275575A1 (enExample)
JP (2) JP6890353B2 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5100911B1 (ja) * 2012-08-09 2012-12-19 ミズ株式会社 生体用高濃度水素ガス供給装置
JP5091364B1 (ja) * 2012-06-04 2012-12-05 ミズ株式会社 生体用水素ガス供給装置
HK1223975A1 (zh) * 2013-12-27 2017-08-11 水活力株式会社 含纳米气泡的组合物及其用途
KR101653937B1 (ko) * 2014-03-13 2016-09-02 미즈 가부시키가이샤 수소 함유 생체 적용액의 제조 방법 및 그것을 위한 외장체
TWI594772B (zh) * 2014-04-18 2017-08-11 林信湧 一種用於治療高血壓之吸入式醫藥組成物及其備製方法
TWI590838B (zh) * 2014-04-18 2017-07-11 林信湧 一種用於治療糖尿病之吸入式醫藥組成物及其備製方法
TWI586382B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療腎臟病之吸入式醫藥組成物及其備製方法
JP2016077675A (ja) * 2014-10-20 2016-05-16 株式会社日本トリム 腹膜透析液の製造装置
JP5900688B1 (ja) * 2015-08-11 2016-04-06 ＭｉＺ株式会社 水素ガス生成装置
EP4495059A3 (en) * 2017-07-27 2025-03-26 Osaka University Silicon nanoparticles for use in treating kidney diseases

Also Published As

Publication number Publication date
JP2021050222A (ja) 2021-04-01
JP2020164507A (ja) 2020-10-08
US20210275575A1 (en) 2021-09-09

Similar Documents

Publication Publication Date Title
Alkhunaizi et al. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure.
Palmer A physiologic-based approach to the evaluation of a patient with hyperkalemia
Schrier Manual of nephrology
TWI440457B (zh) 含檸檬酸及/或檸檬酸鹽之組成物的用途
CN101573124A (zh) 包含氢分子的脂类代谢改善剂
Vychytil et al. Iron status and iron supplementation in peritoneal dialysis patients
Palmer Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose
MXPA06014254A (es) Soluciones para dialisis peritoneal a base de bicarbonato.
Malbrain et al. Treatment of severe thallium intoxication
Abraham et al. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients
US20090304600A1 (en) Intradialytic administration of sodium thiosulfate
US20160038534A1 (en) Method for attenuating free radical formation resulting from a bodily insult
Muldowney et al. Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome
ES2482598T9 (es) Solución para la diálisis peritoneal
JP2021050222A (ja) 分子状水素を含む腎臓疾患の腎機能改善のための組成物
CA2408887C (en) Medical composition kit for treating lesioned abnormal tissue
Cornbleet Bromide intoxication treated with ammonium chloride
US20200368272A1 (en) Composition for ameliorating post-cerebral stroke sequela
Lobo et al. Basic concepts of fluid and electrolyte therapy
Wilson et al. A role of frusemide in resistant hypertension
US7019035B2 (en) Method for attenuating free radical formation resulting from bodily insult
CN116348092B (zh) 输注用高渗复合溶液
Lerma et al. Manual of Nephrology
Kwak et al. Acid/base alterations during major abdominal surgery: 6% hydroxyethyl starch infusion versus 5% albumin
Kaizu et al. Clinical profiles and outcomes of end-stage renal failure patients with late initiation of renal replacement therapy based on uremic symptoms under intensive renoprotective therapies

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20200324

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200508

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20200508

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20200604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200824

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200908

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201208

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20201208

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201217

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210409

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20210409

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210419

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210511

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210518

R150 Certificate of patent or registration of utility model

Ref document number: 6890353

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R157 Certificate of patent or utility model (correction)

Free format text: JAPANESE INTERMEDIATE CODE: R157

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250